Literature DB >> 12656676

Plasminogen activator inhibitor-1 polymers, induced by inactivating amphipathic organochemical ligands.

Katrine E Pedersen1, Anja P Einholm, Anni Christensen, Lotte Schack, Troels Wind, John M Kenney, Peter A Andreasen.   

Abstract

Negatively charged organochemical inactivators of the anti-proteolytic activity of plasminogen activator inhibitor-1 (PAI-1) convert it to inactive polymers. As investigated by native gel electrophoresis, the size of the PAI-1 polymers ranged from dimers to multimers of more than 20 units. As compared with native PAI-1, the polymers exhibited an increased resistance to temperature-induced unfolding. Polymerization was associated with specific changes in patterns of digestion with non-target proteases. During incubation with urokinase-type plasminogen activator, the polymers were slowly converted to reactive centre-cleaved monomers, indicating substrate behaviour of the terminal PAI-1 molecules in the polymers. A quadruple mutant of PAI-1 with a retarded rate of latency transition also had a retarded rate of polymerization. Studying a number of serpins by native gel electrophoresis, ligand-induced polymerization was observed only with PAI-1 and heparin cofactor II, which were also able to copolymerize. On the basis of these results, we suggest that the binding of ligands in a specific region of PAI-1 leads to so-called loop-sheet polymerization, in which the reactive centre loop of one molecule binds to beta-sheet A in another molecule. Induction of serpin polymerization by small organochemical ligands is a novel finding and is of protein chemical interest in relation to pathological protein polymerization in general.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12656676      PMCID: PMC1223451          DOI: 10.1042/BJ20021868

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1: implications for antibody-mediated PAI-1-neutralization and vitronectin-binding.

Authors:  T Wind; M A Jensen; P A Andreasen
Journal:  Eur J Biochem       Date:  2001-02

2.  The structure of a Michaelis serpin-protease complex.

Authors:  S Ye; A L Cech; R Belmares; R C Bergstrom; Y Tong; D R Corey; M R Kanost; E J Goldsmith
Journal:  Nat Struct Biol       Date:  2001-11

Review 3.  Serpins and other covalent protease inhibitors.

Authors:  S Ye; E J Goldsmith
Journal:  Curr Opin Struct Biol       Date:  2001-12       Impact factor: 6.809

4.  A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization.

Authors:  R Egelund; A P Einholm; K E Pedersen; R W Nielsen; A Christensen; J Deinum; P A Andreasen
Journal:  J Biol Chem       Date:  2001-01-25       Impact factor: 5.157

5.  Importance of the amino-acid composition of the shutter region of plasminogen activator inhibitor-1 for its transitions to latent and substrate forms.

Authors:  M Hansen; M N Busse; P A Andreasen
Journal:  Eur J Biochem       Date:  2001-12

6.  The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion.

Authors:  A M Sharp; P E Stein; N S Pannu; R W Carrell; M B Berkenpas; D Ginsburg; D A Lawrence; R J Read
Journal:  Structure       Date:  1999-02-15       Impact factor: 5.006

Review 7.  Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001.

Authors:  K Huber; G Christ; J Wojta; D Gulba
Journal:  Thromb Res       Date:  2001-09-30       Impact factor: 3.944

Review 8.  The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment.

Authors:  Troels Wind; Martin Hansen; Jan K Jensen; Peter A Andreasen
Journal:  Biol Chem       Date:  2002-01       Impact factor: 3.915

9.  Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism.

Authors:  Trevor P Baglin; Robin W Carrell; Frank C Church; Charles T Esmon; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

10.  The vitronectin binding area of plasminogen activator inhibitor-1, mapped by mutagenesis and protection against an inactivating organochemical ligand.

Authors:  Jan K Jensen; Troels Wind; Peter A Andreasen
Journal:  FEBS Lett       Date:  2002-06-19       Impact factor: 4.124

View more
  9 in total

1.  Inhibition of plasminogen activator inhibitor-1 binding to endocytosis receptors of the low-density-lipoprotein receptor family by a peptide isolated from a phage display library.

Authors:  Jan K Jensen; Anders Malmendal; Birgit Schiøtt; Sune Skeldal; Katrine E Pedersen; Leyla Celik; Niels Chr Nielsen; Peter A Andreasen; Troels Wind
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

2.  Loop-sheet mechanism of serpin polymerization tested by reactive center loop mutations.

Authors:  Masayuki Yamasaki; Timothy J Sendall; Laura E Harris; Giles M W Lewis; James A Huntington
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

3.  Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular Disease.

Authors:  Tessa M Simone; Paul J Higgins
Journal:  Mol Med Ther       Date:  2012-08-05

4.  The shapes of Z-α1-antitrypsin polymers in solution support the C-terminal domain-swap mechanism of polymerization.

Authors:  Manja A Behrens; Timothy J Sendall; Jan S Pedersen; Morten Kjeldgaard; James A Huntington; Jan K Jensen
Journal:  Biophys J       Date:  2014-10-21       Impact factor: 4.033

5.  Serpin Inhibition Mechanism: A Delicate Balance between Native Metastable State and Polymerization.

Authors:  Mohammad Sazzad Khan; Poonam Singh; Asim Azhar; Asma Naseem; Qudsia Rashid; Mohammad Anaul Kabir; Mohamad Aman Jairajpuri
Journal:  J Amino Acids       Date:  2011-05-24

6.  Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease.

Authors:  Tessa M Simone; Stephen P Higgins; Craig E Higgins; Michelle R Lennartz; Paul J Higgins
Journal:  J Mol Genet Med       Date:  2014-10

7.  Characterization of the Annonaceous acetogenin, annonacinone, a natural product inhibitor of plasminogen activator inhibitor-1.

Authors:  Stéphane Pautus; Mouad Alami; Fréderic Adam; Guillaume Bernadat; Daniel A Lawrence; Allan De Carvalho; Gilles Ferry; Alain Rupin; Abdallah Hamze; Pierre Champy; Natacha Bonneau; Philippe Gloanec; Jean-Louis Peglion; Jean-Daniel Brion; Elsa P Bianchini; Delphine Borgel
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

Review 8.  Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition.

Authors:  Machteld Sillen; Paul J Declerck
Journal:  Front Cardiovasc Med       Date:  2020-12-22

Review 9.  Serpins in thrombosis, hemostasis and fibrinolysis.

Authors:  J C Rau; L M Beaulieu; J A Huntington; F C Church
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.